申请人:——
公开号:US20040102432A1
公开(公告)日:2004-05-27
The invention provides compounds of formula (I): as modulators of chemokine and H1 receptor activity. The compounds are especially useful in the treatment of asthma and rhinitis.
该发明提供了化合物的公式(I):作为趋化因子和H1受体活性的调节剂。这些化合物在哮喘和鼻炎的治疗中特别有用。